Verition Fund Management’s RenovoRx RNXT Stock Holding History

Verition Fund Management’s Portfolio RNXT Stock Details RNXT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,283	Closed	-$50K	–	2989
2021 Q4	$50K	Buy	+10,283	New	+$61.1K	﹤0.01%	2414

Other funds holding RNXT

LBC

Lawrence B. Cohen $2.06M AUM 34.47% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Verition Fund Management's RNXT Position: Q1 2022 in Review

Verition Fund Management sold out of RenovoRx (RNXT) in Q1 2022, closing a stake of 10,283 shares — an estimated $50K sold.

Verition Fund Management first reported a position in RNXT in Q4 2021 and held it in 1 quarter. The position peaked at $50K in Q4 2021. 12 funds tracked by Wall St. Rank hold RNXT as of Q1 2022.

Verition Fund Management reported no remaining RenovoRx position as of Q1 2022 after selling out during the quarter.
Verition Fund Management sold 10,283 RenovoRx shares in Q1 2022, an estimated $50K.
Verition Fund Management first reported a position in RenovoRx in Q4 2021 and held it in 1 quarter.
Verition Fund Management's RenovoRx position peaked at $50K in Q4 2021.
12 funds tracked by Wall St. Rank held RenovoRx as of Q1 2022.

Based on Verition Fund Management's 13F filing for Q1 2022, filed 13 May 2022.